Add time:08/17/2019         Source:sciencedirect.com

Background & AimsAlthough gadoxetate disodium-enhanced magnetic resonance imaging (MRI) shows higher sensitivity for diagnosing hepatocellular carcinoma (HCC), its arterial-phase images may be unsatisfactory because of weak arterial enhancement. We investigated the clinical effectiveness of arterial subtraction images from gadoxetate disodium-enhanced MRI for diagnosing early-stage HCC using the Liver Imaging Reporting and Data System (LI-RADS) v2018.

We also recommend Trading Suppliers and Manufacturers of GADOXETATE DISODIUM (cas 135326-22-6). Pls Click Website Link as below: cas 135326-22-6 suppliers